Published in Alzheimers Res Ther on August 26, 2010
Brain Stimulation for Neurological Patients | NCT03770182
Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures (DNS) | NCT05153941
Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias. Dement Geriatr Cogn Dis Extra (2012) 0.96
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors. Clin Interv Aging (2013) 0.86
Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One (2013) 0.85
Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice. Alzheimers Res Ther (2011) 0.80
A Psychometric Evaluation of the Threadgold Communication Tool for Persons with Dementia. Dement Geriatr Cogn Dis Extra (2016) 0.80
Activities of daily living in dementia: revalidation of the E-ADL Test and suggestions for further development. BMC Psychiatry (2012) 0.80
Establishing Clinical Relevance in Preclinical Alzheimer's Disease. J Prev Alzheimers Dis (2015) 0.79
Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta -Targeting Vaccine AFFITOPE® AD02 in Early Alzheimer's Disease - Prospective Use of Novel Composite Scales. J Prev Alzheimers Dis (2015) 0.79
Biomarkers to measure treatment effects in Alzheimer's disease: what should we look for? Int J Alzheimers Dis (2011) 0.79
Validation of the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM). BMC Geriatr (2016) 0.76
The CARES(®) Observational Tool: a valid and reliable instrument to assess person-centered dementia care. Geriatr Nurs (2013) 0.76
Degradation in intrinsic connectivity networks across the Alzheimer's disease spectrum. Alzheimers Dement (Amst) (2016) 0.75
The relationship between functional status and judgment/problem solving among individuals with dementia. Int J Geriatr Psychiatry (2012) 0.75
An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog). Psychol Assess (2016) 0.75
Development of a new assessment scale for measuring interaction during staff-assisted transfer of residents in dementia special care units. BMC Geriatr (2015) 0.75
A hybrid intelligent diagnosis approach for quick screening of Alzheimer's disease based on multiple neuropsychological rating scales. Comput Math Methods Med (2015) 0.75
Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study. J Alzheimers Dis (2016) 0.75
Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region. Dement Geriatr Cogn Dis Extra (2016) 0.75
[Cognitive stimulation and music intervention for people with dementia in nursing homes: A pilot study, problems and perspectives]. Z Gerontol Geriatr (2015) 0.75
Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia. J Neurol (2015) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist (1969) 45.63
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA (1963) 38.91
FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J (1965) 38.57
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69
The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32
A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Measurement of functional activities in older adults in the community. J Gerontol (1982) 10.07
Cornell Scale for Depression in Dementia. Biol Psychiatry (1988) 6.61
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci (2000) 6.54
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 5.94
Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist. Psychol Aging (1992) 5.21
Assessing quality of life in older adults with cognitive impairment. Psychosom Med (2002) 4.52
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 4.31
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 3.77
Functional assessment staging (FAST). Psychopharmacol Bull (1988) 3.42
A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol (2007) 3.04
Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry (1987) 2.65
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther (1999) 2.53
Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing (1996) 2.32
Conceptualization and measurement of quality of life in dementia: the dementia quality of life instrument (DQoL). Gerontologist (1999) 2.29
The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry (1995) 2.11
ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord (2006) 1.80
Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc (1986) 1.64
Goal setting and attainment in Alzheimer's disease patients treated with donepezil. J Neurol Neurosurg Psychiatry (2002) 1.62
Assessment of discomfort in advanced Alzheimer patients. Res Nurs Health (1992) 1.59
The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry (2002) 1.59
[Measurement of activities of daily living in patients with dementia living at home: development of a questionnaire]. Tijdschr Gerontol Geriatr (1991) 1.55
The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord (1998) 1.53
The quality of life in late-stage dementia (QUALID) scale. J Am Med Dir Assoc (2003) 1.50
Psychogeriatric dependency rating scales (PGDRS): a method of assessment for use by nurses. Br J Psychiatry (1980) 1.50
Measurement of quality-of-life changes in patients with Alzheimer's disease. Clin Ther (1989) 1.50
What explains differences between dementia patients' and their caregivers' ratings of patients' quality of life? Am J Geriatr Psychiatry (2004) 1.49
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1999) 1.43
A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry (2009) 1.39
The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease. Neurology (1994) 1.27
The Activities of Daily Living Questionnaire: a validation study in patients with dementia. Alzheimer Dis Assoc Disord (2004) 1.26
Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination. J Neurol Neurosurg Psychiatry (2007) 1.20
Quality of life in Alzheimer disease. Alzheimer Dis Assoc Disord (1994) 1.18
The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease. Alzheimer Dis Assoc Disord (2001) 1.13
Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr (2007) 1.10
Quality of Life measures for dementia. Health Qual Life Outcomes (2003) 1.09
A rapid disability rating scale. J Am Geriatr Soc (1967) 1.08
The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials. Dement Geriatr Cogn Disord (2001) 1.05
A new rating scale for dementia syndromes. Arch Gerontol Geriatr (1982) 1.05
Development of a short form of the Severe Impairment Battery. Am J Geriatr Psychiatry (2005) 1.04
Postural knowledge of transitive pantomimes and intransitive gestures. J Int Neuropsychol Soc (2002) 1.03
Scales as outcome measures for Alzheimer's disease. Alzheimers Dement (2009) 1.02
Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES). J Gerontol (1987) 1.00
Health of the Nation Outcome Scales for elderly people (HoNOS 65+). Br J Psychiatry (1999) 1.00
Investigating the effects of communication problems on caregiver burden. J Gerontol B Psychol Sci Soc Sci (2005) 1.00
A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG). J Am Geriatr Soc (1974) 0.99
A new scale for the assessment of depressed mood in demented patients. Am J Psychiatry (1988) 0.98
Validity, reliability and responsiveness of the "Schedule for the Evaluation of Individual Quality of Life-Direct Weighting" (SEIQoL-DW) in congenital heart disease. Health Qual Life Outcomes (2004) 0.94
Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile. Arch Neurol (1996) 0.93
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary care. Prim Care Companion J Clin Psychiatry (2007) 0.92
Relation of linguistic communication abilities of Alzheimer's patients to stage of disease. Brain Lang (1992) 0.92
A new scale for assessing behavioral agitation in dementia. Psychiatry Res (1992) 0.91
Neuropsychological assessment of the severely impaired elderly patient. Clin Geriatr Med (1989) 0.90
Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials. Alzheimers Dement (2008) 0.89
The Bedford Alzheimer Nursing Severity scale for the severely demented: validation study. Alzheimer Dis Assoc Disord (1997) 0.88
Validity and reliability of the dementia behavior disturbance scale. J Am Geriatr Soc (1990) 0.87
Development and validation of the geriatric evaluation by relatives rating instrument (GERRI). Psychol Rep (1983) 0.86
A systematic review of assessment and treatment of moderate to severe Alzheimer's disease. Prim Care Companion J Clin Psychiatry (2006) 0.85
Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients. Alzheimers Dement (2009) 0.84
A new instrument to describe indicators of well-being in old-old patients with severe dementia--the Vienna List. Health Qual Life Outcomes (2004) 0.84
The Neurobehavioral Rating Scale: reliability in patients with dementia. J Psychiatr Res (1995) 0.81
Development and testing of a new outcome measure of relationship between patients with Alzheimer's disease and their partners. Am J Alzheimers Dis Other Demen (2006) 0.81
Comprehension of emotions: comparison between Alzheimer type and vascular type dementias. Dement Geriatr Cogn Disord (2000) 0.79
Characteristics and health status change over 6 months in people with moderately severe to severe Alzheimer's disease in the U.K. Int Psychogeriatr (2006) 0.79
Validation of the 'Vienna List' as a proxy measure of quality of life for geriatric rehabilitation patients. Qual Life Res (2004) 0.79
The Sandoz Clinical Assessment-Geriatric (SCAG) scale. A general-purpose psychogeriatric rating scale. Gerontology (1983) 0.77
Symptoms of communication breakdown in dementia: carers' perceptions. Eur J Disord Commun (1995) 0.76
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Mild cognitive impairment. Lancet (2006) 10.21
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med (2003) 6.79
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol (2004) 5.78
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Alzheimer's disease. Lancet (2011) 5.35
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet (2002) 5.05
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Alzheimer's disease: clinical trials and drug development. Lancet Neurol (2010) 4.65
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol (2006) 4.54
The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol (2005) 4.54
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol (2005) 4.49
Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol (2005) 3.95
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. Am J Epidemiol (2002) 3.70
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord (2007) 3.48
The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord (2003) 3.23
The worldwide economic impact of dementia 2010. Alzheimers Dement (2013) 3.23
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol (2007) 3.22
Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology (2013) 3.20
Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med (2006) 2.90
Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health (2008) 2.86
The worldwide societal costs of dementia: Estimates for 2009. Alzheimers Dement (2010) 2.75
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol (2006) 2.62
Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: a community-based, longitudinal study. Stroke (2003) 2.60
Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Arch Neurol (2005) 2.54
Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc (2009) 2.54
Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease. Am J Epidemiol (2004) 2.35
The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A (2008) 2.30
Mental, physical and social components in leisure activities equally contribute to decrease dementia risk. Dement Geriatr Cogn Disord (2005) 2.19
The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. Eur Heart J (2013) 2.15
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Association between mid-life marital status and cognitive function in later life: population based cohort study. BMJ (2009) 2.00
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Person-centred care of people with severe Alzheimer's disease: current status and ways forward. Lancet Neurol (2008) 1.86
Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc (2003) 1.83
An estimate of the total worldwide societal costs of dementia in 2005. Alzheimers Dement (2007) 1.83
A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin Exp Res (2004) 1.78
Dissociating hippocampal versus basal ganglia contributions to learning and transfer. J Cogn Neurosci (2003) 1.77
Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am J Geriatr Psychiatry (2008) 1.77
Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol (2004) 1.72
Anaemia increases the risk of dementia in cognitively intact elderly. Neurobiol Aging (2006) 1.65
Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc (2007) 1.65
Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ (2003) 1.65
Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am J Pathol (2003) 1.64
The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes (2007) 1.62
Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program. Dement Geriatr Cogn Disord (2006) 1.57
Training-related brain plasticity in subjects at risk of developing Alzheimer's disease. Brain (2011) 1.56
Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project. Am J Psychiatry (2002) 1.55
Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J (2005) 1.54
Partial purification and characterization of gamma-secretase from post-mortem human brain. J Biol Chem (2003) 1.54
A nine-transmembrane domain topology for presenilin 1. J Biol Chem (2005) 1.52
Neurogenic neuroepithelial and radial glial cells generated from six human embryonic stem cell lines in serum-free suspension and adherent cultures. Glia (2007) 1.51
Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ (2004) 1.51
Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J Lipid Res (2003) 1.50
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Ann Neurol (2008) 1.50
Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains. J Neurochem (2009) 1.48
Determinants of costs of care for patients with Alzheimer's disease. Int J Geriatr Psychiatry (2006) 1.47
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Acta Neuropathol (2010) 1.46
Pharmacotherapy of Alzheimer disease. Can J Psychiatry (2007) 1.43
Should physicians prescribe cognitive enhancers to healthy individuals? CMAJ (2012) 1.41
Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology (2008) 1.41
Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr (2008) 1.39
Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem (2004) 1.39
APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch Neurol (2004) 1.36
Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol (2003) 1.36
Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J Neuroimmunol (2002) 1.36
Patient- and proxy-reported utility in Alzheimer disease using the EuroQoL. Alzheimer Dis Assoc Disord (2006) 1.35
Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol (2002) 1.34
The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis (2011) 1.30
Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res Mol Brain Res (2002) 1.27
Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol (2010) 1.26
Phase sensitivity of synaptic modifications in oscillating cells of rat visual cortex. J Neurosci (2004) 1.25
APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol Aging (2008) 1.23
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease. CMAJ (2008) 1.21
The impact of somatic and cognitive disorders on the functional status of the elderly. J Clin Epidemiol (2002) 1.20
Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med (2008) 1.20
Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis (2001) 1.20
Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes (2010) 1.18
Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc Natl Acad Sci U S A (2013) 1.18
Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke (2004) 1.17
Amyloid beta pathology in Alzheimer's disease and schizophrenia. Am J Psychiatry (2003) 1.17
Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One (2008) 1.17
Environmental influences on brain neurotrophins in rats. Pharmacol Biochem Behav (2002) 1.17
Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry (2011) 1.17